Paolino E, Fainardi E, Ruppi P, Tola M R, Govoni V, Casetta I, Monetti V C, Granieri E, Carreras M
Institute of Neurologic Clinic of the University of Ferrara, Italy.
J Neurol Neurosurg Psychiatry. 1996 May;60(5):572-5. doi: 10.1136/jnnp.60.5.572.
A prospective study in patients with a clinical acute isolated brainstem or spinal cord disorder was undertaken. The aim was to evaluate the predictive value of IgG intrathecal synthesis (through the detection of oligoclonal bands in CSF) and MRI lesions at presentation, for the subsequent progression to multiple sclerosis. Forty four patients took part in this study: 22 had a brainstem disorder and 22 a spinal cord disorder. After a mean period of 26 (SD 22) months, 30 patients (68.2%) developed clinically definite multiple sclerosis. The remaining 14 patients were followed up for more than seven years. Twenty six (59.1%) patients had oligoclonal bands in CSF, with a sensitivity of 80.0%, specificity of 85.7%, and a predictive value of 92.2%. Magnetic resonance imaging showed disseminated white matter lesions in 22 patients (50.0%), with a sensitivity of 60.0%, a specificity of 71.4%, and a predictive value of 81.7%. The difference between patients with multiple sclerosis and patients without the disease was statistically significant for the findings of an IgG intrathecal synthesis (P < 0.001). It was only borderline for the MRI findings (P = 0.052). Thus the detection of an intrathecal synthesis at presentation seemed to be a better prognostic indicator of the progression to multiple sclerosis in patients affected by acute isolated brainstem or spinal cord syndromes.
对患有临床急性孤立性脑干或脊髓疾病的患者进行了一项前瞻性研究。目的是评估脑脊液中IgG鞘内合成(通过检测脑脊液中的寡克隆带)和发病时MRI病变对随后发展为多发性硬化症的预测价值。44名患者参与了这项研究:22名患有脑干疾病,22名患有脊髓疾病。平均26(标准差22)个月后,30名患者(68.2%)发展为临床确诊的多发性硬化症。其余14名患者随访了七年多。26名(59.1%)患者脑脊液中有寡克隆带,敏感性为80.0%,特异性为85.7%,预测值为92.2%。磁共振成像显示22名患者(50.0%)有散在的白质病变,敏感性为60.0%,特异性为71.4%,预测值为81.7%。对于IgG鞘内合成的结果,多发性硬化症患者与未患该病的患者之间的差异具有统计学意义(P<0.001)。MRI结果仅为临界值(P = 0.052)。因此,在患有急性孤立性脑干或脊髓综合征的患者中,发病时检测到鞘内合成似乎是发展为多发性硬化症的更好的预后指标。